Latest Pharma and Biotech News
Biotechnology
28 November 2024 Johnson & Johnson has made significant strides in multiple myeloma treatment, with breakthroughs in targeted therapies like CAR-T and bispecific antibodies. At the 2024 ASH meeting, J&J aims to showcase progress, with a goal of achieving a functional cure for multiple myeloma.
Today's issue
Refine Search
Biotechnology
Shares of US biotech CNS Pharmaceuticals gained 4.1% to $4.33 yesterday, after revealing that it has completed an agreement with Houston Pharmaceuticals Inc (HPI) to obtain the rights to a worldwide, exclusive royalty-bearing, license for the chemical compound commonly known as berubicin. 20 November 2019
Biotechnology
Industry analyst GlobalData has highlighted the significance of the POSEIDON study for AstraZeneca’s hopes in non-small-cell lung carcinoma (NSCLC). 19 November 2019
Biotechnology
Ireland-incorporated biotech Alkermes has filed a New Drug Application (NDA) to the US Food and Drug Administration seeking approval of ALKS 3831 (olanzapine/samidorphan) for the treatment of schizophrenia and for the treatment of bipolar I disorder. 19 November 2019
Biotechnology
The market value of Myovant Sciences was up 160% within the opening minutes of trading on Tuesday. 19 November 2019
Biotechnology
US drugmaker The Medicines Company closed 13% higher on Monday and was up a further 26% in Tuesday’s pre-market trading. 19 November 2019
Biotechnology
The PD-1 inhibitors space has become extremely competitive, but the latest data show that there is now an out-right winner in terms of revenue generation. 19 November 2019
Biotechnology
Israeli drugmaker Protalix BioTherapeutics closed 40% up on Monday amid good news for pegunigalsidase alfa, the Fabry disease candidate that it is advancing alongside its development and commercialization partner, Chiesi Farmaceutici. 18 November 2019
Biotechnology
In what is its first outright M&A deal in two decades, Ireland-incorporated biotech firm Alkermes has entered into a definitive agreement to acquire Rodin Therapeutics, a privately held biopharmaceutical company focused on developing novel, small molecule therapeutics for synaptopathies 18 November 2019
Biotechnology
Shares in Boston biotech resTORbio were worth 86% less by Friday’s close after the announcement of top-line data from the Phase III study on the company’s lead candidate. 18 November 2019
Biotechnology
East Coast, USA-based drug developer Dicerna Pharmaceuticals has inked an agreement with Denmark’s Novo Nordisk (NOV: N) to discover and develop novel therapies for liver-related cardio-metabolic diseases. 18 November 2019
Biotechnology
With the US Centers for Disease Control and Prevention (CDC) report on antimicrobial resistance (AMR) stating that it is a much larger and more severe public health threat than previously thought, the AstraZeneca spin-out Entasis Therapeutics (Nasdaq: ETTX) has called for policy change. 18 November 2019
Biotechnology
The US Food and Drug Administration on Friday approved Adakveo (crizanlizumab-tmca), a treatment to reduce the frequency of vaso-occlusive crisis – a common and painful complication of sickle cell disease that occurs when blood circulation is obstructed by sickled red blood cells – for patients aged 16 years and older. 18 November 2019
Biotechnology
US biotech firm Promedior has entered into a definitive agreement to be acquired by Swiss pharma giant Roche. 15 November 2019
Biotechnology
Weeks after presenting positive Phase III trial results on the company’s key pipeline candidate, bimekizumab, UCB has proven that the first study was no fluke. 15 November 2019
Biotechnology
The importance of the year ahead for US biopharma BioMarin Pharmaceutical was made abundantly clear at the company’s R&D Day in New York on Thursday. 15 November 2019
Biotechnology
Fujifilm Diosynth Biotechnologies (FDB), a leading global biologics Contract Development and Manufacturing Organization (CDMO) has announced the expansion of its gene therapy services with the addition of dedicated process and analytical development laboratories. 15 November 2019
Biotechnology
On Thursday, the US Food and Drug Administration granted accelerated approval to Brukinsa (zanubrutinib) capsules for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. 15 November 2019
Biotechnology
An antibiotic from Japanese drugmaker Shionogi has been approved by the US Food and Drug Administration, sending shares in the Osaka-based firm up around 1.5% on Friday. 15 November 2019
Biotechnology
German pharma major Bayer and Dewpoint Therapeutics, today announced an option, research and license agreement worth up to $100 million to the US biotech start-up. 14 November 2019
Biotechnology
A new company has spun out of the UK’s University of Leeds with the stated aim of developing advanced anticoagulants with minimal bleeding risk. 14 November 2019
All news
Biotechnology
AstraZeneca and Daiichi Sankyo’s breast cancer med Enhertu (trastuzumab deruxtecan) will be included in China’s state-run health insurance scheme from next year, boosting availability at the cost of reduced pricing. 29 November 2024
Biotechnology
Minghui Pharmaceutical has reported encouraging results from a Phase III trial of MH004 (tofacitinib etocomil) in mild to moderate atopic dermatitis (AD). 29 November 2024
Biotechnology
Allink Biotherapeutics, a Chinese start-up focused on bispecific antibody and antibody-drug conjugates (ADC), has raised $42 million in a financing round led by Lanchi Ventures. 29 November 2024
Biotechnology
China’s Innovent Biologics has announced that the updated 2024 National Reimbursement Drug List (NRDL) now includes Sintbilo (tafolecimab) injection, an anti-PCSK9 monoclonal antibody for the first time. The updated NRDL will be officially effective from January 1, 2025. 29 November 2024
Biotechnology
Zug-based Galderma has published positive results from the Phase III OLYMPIA 1 trial in JAMA Dermatology, as the company’s newly-minted shares change hands in record volumes. 29 November 2024
Biotechnology
Indian drugmaker Dr Reddy’s Laboratories has launched its toripalimab in the domestic market, sending the firm’s share up 2%. Toripalimab is a New Biological Entity (NBE), the company noted. 29 November 2024
Biotechnology
French pharma major Sanofi has added a new plant in Singapore to make vaccines and other medicines, as the company seeks to bolster preparedness for emergencies, including potential pandemics, according to Bloomberg and other media reports. 29 November 2024
Biotechnology
During the Belgian Economic Mission to Brazil, a historic Memorandum of Understanding (MoU) was signed between the Brazilian Oswaldo Cruz Foundation (Fiocruz) through its Institute of Technology on Immunobiologicals (Bio-Manguinhos), and the Belgian companies Quantoom Biosciences and Univercells. 29 November 2024
Biotechnology
PTC Therapeutics is to sell its rare pediatric disease priority review voucher (PRV) for $150 million. 28 November 2024
Biotechnology
A report from industry analyst DelveInsight highlights progress in the myotonic dystrophy treatment landscape, with more than 20 companies developing over 22 innovative treatments. 28 November 2024
Biotechnology
The UK subsidiary of Dutch drugmaker argenx confirmed today that its investigational therapy, subcutaneous efgartigimod alfa has been granted Promising Innovative Medicine (PIM) designation by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 28 November 2024
Biotechnology
Privately-held French drugmaker Servier has announced the inauguration of its first unit dedicated to the production of biological medicines from its R&D pipeline. 28 November 2024
Biotechnology
The US Food and Drug Administration has received new reports of hematologic malignancies, including life-threatening cases of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), following treatment of early, active cerebral adrenoleukodystrophy (CALD) patients with Skysona (elivaldogene autotemcel). 28 November 2024
Biotechnology
San Diago, USA-based Acadia Pharmaceuticals yesterday announced it has entered into an exclusive worldwide license agreement with Denmark’s Saniona for the development and commercialization of SAN711, a first-in-class, highly selective GABAA-α3 positive allosteric modulator. 28 November 2024
Biotechnology
Kronos Bio, a biotech with a presence on the east and west coasts of the USA, has unveiled a major restructuring plan. 28 November 2024
Biotechnology
Johnson & Johnson has made significant strides in multiple myeloma treatment, with breakthroughs in targeted therapies like CAR-T and bispecific antibodies. At the 2024 ASH meeting, J&J aims to showcase progress, with a goal of achieving a functional cure for multiple myeloma. 28 November 2024
Biotechnology
The European medicines regulator has approved a combo therapy starring PD-1 inhibitor Tevimbra (tislelizumab), from cancer firm BeiGene. 27 November 2024
Biotechnology
After trading closed yesterday, Exelixis revealed that the US Food and Drug Administration (FDA) has notified the company that the supplemental New Drug Application (sNDA) for cabozantinib (Cabometyx) for the treatment of adults with previously treated advanced pancreatic neuroendocrine tumors (pNET) and advanced extra-pancreatic NET (epNET) will be discussed at an Oncologic Drugs Advisory Committee (ODAC) meeting in March 2025. 27 November 2024
Biotechnology
Chengdu-based Kelun-Biotech has received marketing authorization in China for sacituzumab tirumotecan (sac-TMT), a Trop2-directed antibody-drug conjugate (ADC). 27 November 2024
Biotechnology
AI-powered protein engineering company Cradle has raised $73 million in a Series B funding. The European firm, which has now raised more than $100 million in total, calls itself the leading platform for AI-powered protein engineering. 27 November 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze